Experienced healthcare and consumer digital operator turned growth investor, focused on early-stage software and services that improve care coordination and patient engagement. Sarah Kopesky leverages operating roles scaling product and commercial teams, board advisory experience, and investor diligence to back founder-led companies. Known for strategic go-to-market and metrics-driven scaling.
Experienced healthcare and consumer digital operator turned growth investor, focused on early-stage software and services that improve care coordination and patient engagement. Sarah Kopesky leverages operating roles scaling product and commercial teams, board advisory experience, and investor diligence to back founder-led companies. Known for strategic go-to-market and metrics-driven scaling.
Prioritizes early-stage healthcare and consumer digital software that improves care coordination and patient engagement, backing founder-led teams with hands-on operational support. Investment thesis favors product-led growth, repeatable go-to-market motion, and metric-driven KPIs at seed to Series A. Capital allocation blends active follow-on reserves with disciplined milestones, emphasizing unit economics, customer retention, and pragmatic scaling roadmaps to de-risk commercialization.
Prioritizes early-stage healthcare and consumer digital software that improves care coordination and patient engagement, backing founder-led teams with hands-on operational support. Investment thesis favors product-led growth, repeatable go-to-market motion, and metric-driven KPIs at seed to Series A. Capital allocation blends active follow-on reserves with disciplined milestones, emphasizing unit economics, customer retention, and pragmatic scaling roadmaps to de-risk commercialization.
| Trades 246 | Longs Won 117/246 47% | Profit Factor 2.47 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $307,319.26 |
| Average Win $154,469.34 | Best Trade (Mar 31) $3.19M | Sharpe Ratio -9.09 |
| Average Loss -$56,809.13 | Worst Trade (Jun 29) -$798,159.88 | Z-Score -1.05 (70.72%) |
| Commissions $0 | Avg. Trade Length 6m 3d | Expectancy $43,676.97 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.21% | 5.45% |
| Consecutive Losing Trades | 529 | 476 | 423 | 370 | 317 | 264 | 211 | 159 | 106 | 53 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BUFR FT Vestladder Buffer ETF-USD I | 47,275 | $1.49M | $1.74M | - | $243,819.19 | 16.31% | +0.41% |
EFA iShares MSCI EAFE ETF | 36,260 | $3.39M | $3.83M | - | $442,734.8 | 13.08% | -0.621% |
ESN Essential 40 Stock ETF | 118,222 | $2.03M | $2.37M | - | $337,724.74 | 16.65% | +0.286% |
IVV iShares Core S&P 500 ETF | 3,333 | $2.23M | $2.5M | - | $270,035.75 | 12.1% | +0.687% |
IWM iShares Russell 2000 ETF | 12,642 | $3.06M | $3.68M | - | $622,492.47 | 20.35% | -0.475% |
JMTG JPMorgan Mortgage-Backed Securities ETF | 84,183 | $4.29M | $4.21M | - | -$85,874.8 | -2% | -0.379% |
NUKZ Range Nuclear Renaissance ETF | 10,489 | $666,051.53 | $667,939.52 | - | $1,887.99 | 0.28% | -0.204% |
QQQ Invesco QQQ Trust, Series 1 | 2,253 | $1.35M | $1.55M | - | $200,901.2 | 14.89% | +0.65% |
SCHZ Schwab U.S. Aggregate Bond ETF | 19,441 | $454,336.14 | $442,477.16 | - | -$11,858.98 | -2.61% | -0.307% |
SCYB Schwab High Yield Bond ETF | 9,993 | $264,015.09 | $259,917.93 | - | -$4,097.16 | -1.55% | +0.077% |
SGOV iShares 0-3 Month Treasury Bond ETF | 18,280 | $1.84M | $1.84M | - | $182.8 | 0.01% | +0.02% |
SPY SPDR S&P 500 ETF Trust | 7,226 | $4.81M | $5.4M | - | $584,222.01 | 12.14% | +0.72% |
STCE Schwab Crypto Thematic ETF | 4,165 | $249,733.44 | $260,145.9 | - | $10,412.46 | 4.17% | -4.085% |
XAR SPDR S&P Aerospace & Defense ETF | 2,673 | $644,834.51 | $707,970.75 | - | $63,136.24 | 9.79% | +0.772% |